tepoxalin has been researched along with leukotriene b4 in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aparicio, BL; Argentieri, DC; Barbone, AG; Lau, CY; Plante, RK; Ritchie, DM | 1 |
Arnout, J; Baldauf, C; Brunner, F; Chow, A; De Broe, M; De Schepper, PJ; Depré, M; Jurgens, A; Pousset, V; Van Hecken, A; Verbesselt, R; Vermylen, J; Verpooten, GA | 1 |
Aparicio, B; Argentieri, DC; Kirchner, T; Lau, CY; Ritchie, DM | 1 |
Kleemeyer, KS; Peskar, BA; Schmidt, K; Willburger, RE; Wittenberg, RH | 1 |
Anderson, DC; Casadevall, M; Conill, C; Granger, DN; Mollà, M; Panés, J; Piqué, JM; Roselló-Catafau, J; Salas, A; Sans, M | 1 |
Lin, TY; London, CA | 1 |
Budsberg, SC; Goodman, LA; Reynolds, LR; Torres, BT | 1 |
2 trial(s) available for tepoxalin and leukotriene b4
Article | Year |
---|---|
Biochemical activity, pharmacokinetics and tolerability of tepoxalin, a cyclooxygenase/5-lipoxygenase inhibitor, in man.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Cyclooxygenase Inhibitors; Double-Blind Method; Gastrointestinal Diseases; Humans; Leukotriene B4; Lipoxygenase Inhibitors; Liver Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Thromboxane B2 | 1996 |
Antiinflammatory effect of tepoxalin: blood and synovial tissue studied in patients with knee arthrosis.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthroplasty, Replacement, Knee; Dinoprostone; Double-Blind Method; Drug Administration Schedule; Female; Humans; Knee Joint; Leukotriene Antagonists; Leukotriene B4; Leukotriene C4; Male; Middle Aged; Pain; Pain Measurement; Premedication; Pyrazoles; Radioimmunoassay; Synovial Membrane; Thromboxane B2 | 1998 |
5 other study(ies) available for tepoxalin and leukotriene b4
Article | Year |
---|---|
Cytokine-modulating activity of tepoxalin, a new potential antirheumatic.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Cell Division; Cells, Cultured; Cytokines; Ferrous Compounds; Humans; Immunosuppressive Agents; Leukocytes, Mononuclear; Leukotriene B4; NF-kappa B; Pyrazoles | 1995 |
Effects of tepoxalin, a dual inhibitor of cyclooxygenase/5-lipoxygenase, on events associated with NSAID-induced gastrointestinal inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Adhesion; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Female; Gastric Mucosa; Gastroenteritis; Indomethacin; Leukotriene B4; Lipid Peroxides; Lipoxygenase Inhibitors; Mesenteric Veins; Neutrophils; Pyrazoles; Rats; Rats, Sprague-Dawley | 1997 |
Tepoxalin inhibits inflammation and microvascular dysfunction induced by abdominal irradiation in rats.
Topics: Abdomen; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Adhesion; Digestive System; Inflammation; Leukocytes; Leukotriene B4; Male; Permeability; Pyrazoles; Radiotherapy; Rats; Rats, Sprague-Dawley | 2000 |
Characterization and modulation of canine mast cell derived eicosanoids.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Carbazoles; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Dogs; Leukotriene Antagonists; Leukotriene B4; Leukotriene C4; Leukotrienes; Masoprocol; Mast Cells; Piroxicam; Prostaglandin Antagonists; Prostaglandin D2; Prostaglandins; Pyrazoles; Sulfonamides | 2010 |
Effects of firocoxib, meloxicam, and tepoxalin administration on eicosanoid production in target tissues of healthy cats.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cats; Cross-Over Studies; Cyclooxygenase Inhibitors; Dinoprostone; Duodenum; Eicosanoids; Gastric Mucosa; Intestinal Mucosa; Kinetics; Leukotriene B4; Male; Meloxicam; Orchiectomy; Pyrazoles; Reference Values; Sulfones; Thiazines; Thiazoles | 2010 |